Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.60 |
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | CES2 | O00748 | 1/20 | 0.49 |
| ▸ | CES1 | P23141 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | CRHBP | P24387 | 1/20 | 0.45 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.45 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.45 |
| ▸ | PPIA | P62937 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1665203 | 0.85 | ALDH1A1 (0.46) | TSHRALDH1A1CYP3A4RECQLHSD17B10 | |
| SCHEMBL6693481 | 0.83 | MAPT (0.56) | TSHRALDH1A1CYP3A4RECQLHSD17B10 | |
| SCHEMBL6840900 | 0.80 | TSHR (0.56) | TSHRALDH1A1CYP3A4HSD17B10MEN1 | |
| SCHEMBL171914 | 0.78 | TSHR (0.72) | TSHRALDH1A1CYP3A4RECQLHSD17B10 | |
| SCHEMBL29613904 | 0.78 | TSHR (0.72) | TSHRALDH1A1CYP3A4RECQLHSD17B10 | |
| SCHEMBL14371934 | 0.78 | MAPT (0.43) | TSHRALDH1A1CYP3A4HSD17B10CES1 | |
| SCHEMBL1665978 | 0.78 | PARP1 (0.56) | TSHRALDH1A1CYP3A4MEN1KMT2A | |
| SCHEMBL7190826 | 0.78 | TSHR (0.64) | TSHRALDH1A1CYP3A4RECQLHSD17B10 | |
| SCHEMBL2340894 | 0.77 | ALDH1A1 (0.49) | TSHRALDH1A1CYP3A4RECQLHSD17B10 | |
| SCHEMBL23293742 | 0.77 | TSHR (0.62) | TSHRALDH1A1CYP3A4RECQLHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260028330-A1 | HETEROARYL CARBOXAMIDE AND RELATED GPR84 ANTAGONISTS AND USES THEREOF | LIMINAL BIOSCIENCES LTD (GB) | 2026-01-29 | — | — | US | disclosed |
| EP-4565568-A1 | HETEROARYL CARBOXAMIDE AND RELATED GPR84 ANTAGONISTS AND USES THEREOF | Liminal Biosciences Limited (GB) | 2025-06-11 | — | — | EP | disclosed |
| CN-120019047-A | Heteroaryl carboxamides and related GPR84 antagonists and uses thereof | 里米诺生物科学有限公司 | 2025-05-16 | — | — | CN | disclosed |
| WO-2024028363-A1 | HETEROARYL CARBOXAMIDE AND RELATED GPR84 ANTAGONISTS AND USES THEREOF | Liminal Biosciences Limited (GB) | 2024-02-08 | — | — | WO | disclosed |
| WO-2023202625-A1 | FGFR2 INHIBITOR AND METHOD FOR USING SAME | 深圳福沃药业有限公司 | 2023-10-26 | — | — | WO | disclosed |
| CN-116903628-A | FGFR2 inhibitors and methods of use | 深圳福沃药业有限公司 | 2023-10-20 | — | — | CN | disclosed |
| CN-116813475-A | Halogenated synthesis method of aromatic ring compound | 北京大学 | 2023-09-29 | — | — | CN | disclosed |
| WO-2022220625-A1 | PROTEIN DEGRADER CONJUGATES AND USE THEREOF | 주식회사 레고켐바이오사이언스 | 2022-10-20 | — | — | WO | disclosed |
| CN-113387823-B | Anthranilic acid and derivative thereof, and synthetic method and application thereof | 华东师范大学 | 2022-07-08 | — | — | CN | disclosed |
| CN-112939948-B | Novel quinazoline-containing compound, intermediate and application thereof | 苏州美诺医药科技有限公司 | 2022-05-17 | — | — | CN | disclosed |
| US-5844110-A | Synthetic triple helix-forming compound precursors | UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) | 1998-12-01 | — | — | US | disclosed |
| EP-0869787-A1 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-10-14 | — | — | EP | disclosed |
| WO-1997037999-A1 | SYNTHETIC TRIPLE HELIX-FORMING COMPOUNDS | UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) | 1997-10-16 | — | — | WO | disclosed |
| WO-1997024124-A1 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-07-10 | — | — | WO | disclosed |
| WO-1997024122-A1 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-07-10 | — | — | WO | disclosed |
| WO-1997024119-A1 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-07-10 | — | — | WO | disclosed |
| WO-1996023777-A1 | SYNTHETIC TRIPLE HELIX-FORMING COMPOUNDS | UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) | 1996-08-08 | — | — | WO | disclosed |
| US-4812162-A | PLANT GROWTH REGULATORS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1989-03-14 | — | — | US | disclosed |
| EP-0274825-A2 | Indole derivatives and their uses in agriculture | ZENECA LIMITED (GB) | 1988-07-20 | — | — | EP | disclosed |
| US-4020107-A | ACIDIC PHOSPHORUS COMPOUND DEHALOGENATION INHIBITOR | E. I. DU PONT DE NEMOURS AND CO. (US) | 1977-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028330-A1 | HETEROARYL CARBOXAMIDE AND RELATED GPR84 ANTAGONISTS AND USES THEREOF | GPR84, GPR88, GPR68 | TSHR 690/4885ALDH1A1 1033/4885CYP3A4 1491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.